Exemio press kit

Boilerplate

One sentence

Exemio is an iPhone eczema diary and tracker: you log itch, skin, sleep, stress, meals and supplements in seconds (or tell Lumi in one sentence), and it summarizes possible triggers and patterns in your own log — ranked by how strong the link is. Not a medical device.

One paragraph

Exemio is an iPhone eczema diary and tracker built by Jakub Pilch, a software developer from Ostrava, Czech Republic, who has lived with eczema since childhood. You log itch, skin, sleep, stress, meals and supplements in seconds — or tell Lumi, the in-app assistant, about your day in one sentence — and Exemio compares your good and bad days to summarize possible triggers and patterns in your own log, ranked by how strong the link is. It is free to download, stores data in the EU, never sells it and takes no skin photos. Exemio is not a medical device.

Facts

Name

Exemio (App Store title: "Exemio: Eczema Tracker & Diary"; Czech storefront: "Exemio: deník ekzému"). App Store ID 6757302855.

Developer

Jakub Pilch, independent developer; no investors. (The App Store currently shows the seller as "JAKUB MILCH" — a typo in the Apple developer registration.)

Based in

Ostrava, Czech Republic.

Launched

21 January 2026 on the App Store.

Current version

1.12.0, released 8 October 2026 (as of 23 October 2026).

Platforms

iPhone and iPad, iOS 15.1 or later. Not on Google Play.

Languages

English, Czech, Spanish, French, Portuguese — the whole app, including analyses, the PDF summary and Lumi chat. Slovak devices get the Czech interface.

Price

Free to download. Optional Premium: $6.99 a month, or $59.99 a year with a 7-day free trial for new subscribers (US App Store, as of October 23, 2026); full table at exemio.app/pricing.

AI

Google Gemini for Lumi chat, log parsing and the first-days note; Anthropic Claude for Quick Insight, Full Analysis and the Deep Dive report. Since version 1.12, AI runs only with the user's consent and can be switched off in Profile. AI providers do not train on user data.

Privacy

Data stored in the EU, encrypted in transit and at rest, never sold; no advertising SDKs; no photos — Exemio does not take or store skin photos. Account and data can be deleted anytime.

Medical status

Not a medical device. Does not diagnose or treat any condition. For people aged 16 and over.

App Store category

Health & Fitness.

EczemaWise

EczemaWise (National Eczema Association) ends on December 18, 2026. Exemio imports its history from screenshots, a PDF or pasted text. Exemio is not affiliated with the National Eczema Association.

Website

exemio.app (English) and exemio.app/cs (Czech).

What the app does

• Log in seconds: Skin Pulse (rate your skin from 1 to 10), one-tap logging from the daily reminder, or a full diary entry (food, supplements, stress, sleep, water, alcohol, cycle, notes). Or tell Lumi "skin 6/10, pizza for dinner, stressful day" and she logs it.
• Quick Insight: a short read on your recent days (one free every 7 days; unlimited with Premium).
• Full Analysis (Premium): compares good and bad days and lists possible triggers and patterns, ranked by how strongly they are linked to your flares. Needs at least 3 logged days; correlations need 5.
• Deep Dive: the most detailed report, over up to 90 days of logs, bought separately as a one-time credit.
• Lumi chat: ask questions about your own data, such as "Is my skin worse after bad sleep?" (up to 5 messages a day on a free account).
• Streaks and a calendar; full export of your logs anytime; PDF summary for your dermatologist (Premium).

Story angles we can back up

Founder

Jakub Pilch is a software developer based in Ostrava, Czech Republic. He has lived with eczema since childhood and builds Exemio himself. He is not a doctor and has no medical training, which the site states openly.

Quotes you may use

• "Dermatologists told me to avoid my triggers without telling me how to find them. Exemio is the diary I wished I had: fast enough to keep up every day, and honest enough to call a pattern a lead for my dermatologist rather than a diagnosis." — Jakub Pilch, founder
• "It is not a medical device and it won't diagnose anything. What it gives you is a lead — something concrete to bring to your doctor instead of a vague memory of a bad month." — Jakub Pilch, founder

Assets

Use the icon as is; please don't recolor it. Screenshots are on the App Store listing; press-resolution files are available on request.

• App icon, 512 × 512 PNG →Also used as the site's social image.
• App Store listing (screenshots, description, version history) →The listing is the source of truth for prices and version.
• Founder photo, Jakub Pilch (JPG, 800 × 1000) →The same photo as on the About page. Credit: Exemio.

What we don't publish

• User, download or revenue numbers — the app launched in January 2026 and we don't want small numbers dressed up as traction.
• Before/after skin photos, efficacy percentages or "found their trigger" success rates. The app shows patterns in a log; it does not measure outcomes.
• Claims about treating, curing or diagnosing eczema, in any language.

Contact

hello@exemio.app for press enquiries. Threads: @pil_kuba_. LinkedIn: linkedin.com/in/pilch-jakub.

Useful pages